-
1
-
-
65349129804
-
-
Chinese source.
-
Chinese source.
-
-
-
-
2
-
-
0035750549
-
Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy [J]
-
Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong YP, Ingles SA, Sherrod A, et al. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy [J]. Pharmacogenomics J, 2001, 1 (1): 65-70.
-
(2001)
Pharmacogenomics J
, vol.1
, Issue.1
, pp. 65-70
-
-
Pullarkat, S.T.1
Stoehlmacher, J.2
Ghaderi, V.3
Xiong, Y.P.4
Ingles, S.A.5
Sherrod, A.6
-
3
-
-
33847611097
-
Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel[J]
-
Nief N, Le Morvan V, Robert J. Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel[J]. Eur J Cancer, 2007, 43 (5): 955-962.
-
(2007)
Eur J Cancer
, vol.43
, Issue.5
, pp. 955-962
-
-
Nief, N.1
Le Morvan, V.2
Robert, J.3
-
4
-
-
38749114233
-
Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients[J]
-
Kuramochi H, Tanaka K, Oh D, Lehman BJ, Dunst CM, Yang DY, et al. Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients[J]. Int J Oncol, 2008, 32 (1): 201-208.
-
(2008)
Int J Oncol
, vol.32
, Issue.1
, pp. 201-208
-
-
Kuramochi, H.1
Tanaka, K.2
Oh, D.3
Lehman, B.J.4
Dunst, C.M.5
Yang, D.Y.6
-
5
-
-
34548751568
-
Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer[J]
-
Matsui T, Omura K, Kawakami K, Morita S, Sakamoto J. Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer[J]. Oncol Rep, 2006, 16(5): 1111-1115.
-
(2006)
Oncol Rep
, vol.16
, Issue.5
, pp. 1111-1115
-
-
Matsui, T.1
Omura, K.2
Kawakami, K.3
Morita, S.4
Sakamoto, J.5
-
6
-
-
31544462629
-
Thymidylate synthase pharmacogenetics [J]
-
Marsh S. Thymidylate synthase pharmacogenetics [J]. Invest New Drugs, 2005, 23(6): 533-537.
-
(2005)
Invest New Drugs
, vol.23
, Issue.6
, pp. 533-537
-
-
Marsh, S.1
-
7
-
-
33644700573
-
Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis [J]
-
Krajinovic M, Costea I, Primeau M, Dulucq S, Moghrabi A. Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis [J]. Pharmacogenomics J, 2005, 5 (6): 374-380.
-
(2005)
Pharmacogenomics J
, vol.5
, Issue.6
, pp. 374-380
-
-
Krajinovic, M.1
Costea, I.2
Primeau, M.3
Dulucq, S.4
Moghrabi, A.5
-
8
-
-
23844544276
-
Pharmacogenomics of thymidylate synthase in cancer treatment[J]
-
Danenberg PV. Pharmacogenomics of thymidylate synthase in cancer treatment[J]. Front Biosci, 2004, 9:2484-2494.
-
(2004)
Front Biosci
, vol.9
, pp. 2484-2494
-
-
Danenberg, P.V.1
-
9
-
-
1342301546
-
Thymidylate synthase and methylenetetra-hydrofolate reductase gene polymorphisms: Relationships with 5-fluorouracil sensitivity[J]
-
Etienne MC, Ilc K, Formento JL, Laurent-Puig P, Formento P, Cheradame S, et al. Thymidylate synthase and methylenetetra-hydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity[J]. Br J Cancer, 2004, 90(2): 526-534.
-
(2004)
Br J Cancer
, vol.90
, Issue.2
, pp. 526-534
-
-
Etienne, M.C.1
Ilc, K.2
Formento, J.L.3
Laurent-Puig, P.4
Formento, P.5
Cheradame, S.6
-
10
-
-
65349094962
-
-
Chinese source.
-
Chinese source.
-
-
-
-
11
-
-
65349120427
-
-
Chinese source.
-
Chinese source.
-
-
-
-
12
-
-
65349149773
-
-
Chinese source.
-
Chinese source.
-
-
-
-
13
-
-
65349121585
-
-
Chinese source.
-
Chinese source.
-
-
-
-
14
-
-
33745728357
-
A DGGE System for comprehentive Mutation Screening of BRCA1 and BRCA2: Application in a Dutch Cancer Clinic Setting [J]
-
van der Hout AH, van den Ouweland AM, van der Luijt RB, Gille HJ, Bodmer D, Brüggenwirth H, et al. A DGGE System for comprehentive Mutation Screening of BRCA1 and BRCA2: Application in a Dutch Cancer Clinic Setting [J]. Hum Mutat, 2006, 27 (7): 654-666.
-
(2006)
Hum Mutat
, vol.27
, Issue.7
, pp. 654-666
-
-
van der Hout, A.H.1
van den Ouweland, A.M.2
van der Luijt, R.B.3
Gille, H.J.4
Bodmer, D.5
Brüggenwirth, H.6
-
15
-
-
25444468843
-
Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGCE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations [J]
-
Rendtorff ND, Bjerregaard B, Frödin M, Kjaergaard S, Hove H, Skovby F, et al. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGCE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations [J]. Hum Mutat, 2005, 26 (4): 374-383.
-
(2005)
Hum Mutat
, vol.26
, Issue.4
, pp. 374-383
-
-
Rendtorff, N.D.1
Bjerregaard, B.2
Frödin, M.3
Kjaergaard, S.4
Hove, H.5
Skovby, F.6
-
16
-
-
5044231544
-
Sequence variations of the alpha-globin genes: Scanning of high CG content genes with DHPLC and DG-DGGE [J]
-
Lacerra G, Fiorito M, Musollino G, Di Noce F, Esposito M, Nigro V, et al. Sequence variations of the alpha-globin genes: scanning of high CG content genes with DHPLC and DG-DGGE [J]. Hum Mutat, 2004, 24(4): 338-349.
-
(2004)
Hum Mutat
, vol.24
, Issue.4
, pp. 338-349
-
-
Lacerra, G.1
Fiorito, M.2
Musollino, G.3
Di Noce, F.4
Esposito, M.5
Nigro, V.6
|